ARAF mutations confer resistance to RAF dimer inhibitors in NRAS and BRAF mutant melanoma.

被引：0
|
作者：
Malek, Shiva [1 ]
机构：
[1] Genentech Inc, San Francisco, CA USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
36
引用
收藏
页数：2
相关论文
共 50 条
  • [31] BRAF and NRAS mutations in Metastatic Melanoma Patients with Leptomeningeal Disease
    Patel, Sapna Pradyuman
    Lam, Sruti
    Rohlfs, Michelle L.
    Fox, Patricia S.
    Richard, Jessie
    Iqbal, Masood
    Bernzen, Theresa
    Glitza, Isabella Claudia
    Papadopoulos, Nicholas E.
    Hwu, Patrick
    Davies, Michael A.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [32] BRAF and NRAS Mutations are Heterogeneous and Not Mutually Exclusive in Nodular Melanoma
    Chiappetta, Caterina
    Proietti, Ilaria
    Soccodato, Valentina
    Puggioni, Chiara
    Zaralli, Roberto
    Pacini, Luca
    Porta, Natale
    Skroza, Nevena
    Petrozza, Vincenzo
    Potenza, Concetta
    Della Rocca, Carlo
    Di Cristofano, Claudio
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2015, 23 (03) : 172 - 177
  • [33] BRAF, KIT, and NRAS Mutations of Acral Melanoma in White Patients
    Dika, Emi
    Veronesi, Giulia
    Altimari, Annalisa
    Riefolo, Mattia
    Ravaioli, Giulia Maria
    Piraccini, Bianca Maria
    Lambertini, Martina
    Campione, Elena
    Gruppioni, Elisa
    Fiorentino, Michelangelo
    Melotti, Barbara
    Ferracin, Manuela
    Patrizi, Annalisa
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2020, 153 (05) : 664 - 671
  • [34] Tumor Heterogeneity in Metastatic Melanoma Patients with BRAF/NRAS Mutations
    Yoon, C. H.
    Le, J.
    Ibrahim, N.
    Gold, J.
    Bertagnolli, M. M.
    Hodi, F. S.
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : S23 - S23
  • [35] Somatic BRAF and NRAS mutations in familial melanoma: a GenoMEL study
    Zebary, Abdlsattar
    Omholt, Katarina
    van Nieuwpoort, Frans A.
    Ghiorzo, Paola
    Gruis, Nelleka A.
    Harbst, Katja
    Hayward, Nicholas K.
    Jonsson, Goran B.
    Pjanova, Dace
    Puig, Susana
    Scarra, Giovanna B.
    Whitaker, Linda M.
    Newton-Bishop, Julia
    Hansson, Johan
    CANCER RESEARCH, 2011, 71
  • [36] Prevalence of BRAF and NRAS mutations in cutaneous melanoma patients in Taiwan
    Sheen, Yi-Shuan
    Liao, Yi-Hua
    Liau, Jau-Yu
    Lin, Ming-Hsien
    Hsieh, Yi-Chun
    Jee, Shiou-Hwa
    Chu, Chia-Yu
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2016, 115 (02) : 121 - 127
  • [37] Examination of mutations in BRAF, NRAS, and PTEN in primary cutaneous melanoma
    Goel, Vikas K.
    Lazar, Alexander J. F.
    Warneke, Carla L.
    Redston, Mark S.
    Haluska, Frank G.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 (01) : 154 - 160
  • [38] Clinical Correlates of NRAS and BRAF Mutations in Primary Human Melanoma
    Ellerhorst, Julie A.
    Greene, Victoria R.
    Ekmekcioglu, Suhendan
    Warneke, Carla L.
    Johnson, Marcella M.
    Cooke, Carolyn P.
    Wang, Li-E
    Prieto, Victor G.
    Gershenwald, Jeffrey E.
    Wei, Qingyi
    Grimm, Elizabeth A.
    CLINICAL CANCER RESEARCH, 2011, 17 (02) : 229 - 235
  • [39] Amuvatinib has cytotoxic effects against NRAS-mutant melanoma but not BRAF-mutant melanoma
    Fedorenko, Inna V.
    Fang, Bin
    Koomen, John M.
    Gibney, Geoffrey T.
    Smalley, Keiran S. M.
    MELANOMA RESEARCH, 2014, 24 (05) : 448 - 453
  • [40] LncRNA SAMMSON Mediates Adaptive Resistance to RAF Inhibition in BRAF-Mutant Melanoma Cells
    Han, Shujun
    Yan, Yuwei
    Ren, Yibo
    Hu, Yiming
    Wang, Yan
    Chen, Lei
    Zhi, Zhe
    Zheng, Yan
    Shao, Yongping
    Liu, Jiankang
    CANCER RESEARCH, 2021, 81 (11) : 2918 - 2929
12345